2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001639:Bicarbonates / Q000494:pharmacology / Q000627:therapeutic use; D001786:Blood Glucose; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy / Q000378:metabolism*; D016883:Diabetic Ketoacidosis / Q000209:etiology; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005994:Glycerophosphates / Q000097:blood*; D006454:Hemoglobins; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007328:Insulin / Q000627:therapeutic use; D007651:Keto Acids / Q000097:blood; D007657:Ketone Bodies / Q000097:blood; D007773:Lactates / Q000097:blood; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption; D010313:Partial Pressure; D011773:Pyruvates / Q000097:blood
D001639:Bicarbonates; D001786:Blood Glucose; D005994:Glycerophosphates; D006454:Hemoglobins; D007328:Insulin; D007651:Keto Acids; D007657:Ketone Bodies; D007773:Lactates; D011773:Pyruvates; D010100:Oxygen